These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8616837)
1. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. Hamann U; Herbold C; Costa S; Solomayer EF; Kaufmann M; Bastert G; Ulmer HU; Frenzel H; Komitowski D Cancer Res; 1996 May; 56(9):1988-90. PubMed ID: 8616837 [TBL] [Abstract][Full Text] [Related]
2. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors. Kerangueven F; Allione F; Noguchi T; Adélaïde J; Sobol H; Jacquemier J; Birnbaum D Genes Chromosomes Cancer; 1995 Aug; 13(4):291-4. PubMed ID: 7547638 [TBL] [Abstract][Full Text] [Related]
3. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma. Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988 [TBL] [Abstract][Full Text] [Related]
4. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Collins N; McManus R; Wooster R; Mangion J; Seal S; Lakhani SR; Ormiston W; Daly PA; Ford D; Easton DF Oncogene; 1995 Apr; 10(8):1673-5. PubMed ID: 7731724 [TBL] [Abstract][Full Text] [Related]
5. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer. Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754 [TBL] [Abstract][Full Text] [Related]
6. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors. van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173 [TBL] [Abstract][Full Text] [Related]
7. High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation. Ingvarsson S; Geirsdottir EK; Johannesdottir G; Sigbjörnsdóttir BI; Eiriksdottir G; Ragnarsson G; Agnarsson BA; Gudmundsson J; Jonasson JG; Sigurdsson A; Egilsson V; Barkardottir RB Cancer Res; 1998 Oct; 58(19):4421-5. PubMed ID: 9766673 [TBL] [Abstract][Full Text] [Related]
8. Distinct regions of allelic loss on 13q in prostate cancer. Cooney KA; Wetzel JC; Merajver SD; Macoska JA; Singleton TP; Wojno KJ Cancer Res; 1996 Mar; 56(5):1142-5. PubMed ID: 8640774 [TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer. Bièche I; Lidereau R Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660 [TBL] [Abstract][Full Text] [Related]
10. Isolation of expressed sequences that include a gene for familial breast cancer (BRCA2) and other novel transcripts from a five megabase region on chromosome 13q12. Jacob AN; Kandpal G; Kandpal RP Oncogene; 1996 Jul; 13(1):213-21. PubMed ID: 8700550 [TBL] [Abstract][Full Text] [Related]
11. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Gudmundsson J; Johannesdottir G; Bergthorsson JT; Arason A; Ingvarsson S; Egilsson V; Barkardottir RB Cancer Res; 1995 Nov; 55(21):4830-2. PubMed ID: 7585515 [TBL] [Abstract][Full Text] [Related]
12. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. Ingvarsson S; Agnarsson BA; Sigbjornsdottir BI; Kononen J; Kallioniemi OP; Barkardottir RB; Kovatich AJ; Schwarting R; Hauck WW; Huebner K; McCue PA Cancer Res; 1999 Jun; 59(11):2682-9. PubMed ID: 10363992 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of BRCA2 gene in sporadic breast tumours. Bièche I; Noguès C; Lidereau R Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873 [TBL] [Abstract][Full Text] [Related]
14. Allelic loss on chromosome 13q in human prostate carcinoma. Melamed J; Einhorn JM; Ittmann MM Clin Cancer Res; 1997 Oct; 3(10):1867-72. PubMed ID: 9815575 [TBL] [Abstract][Full Text] [Related]
15. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas. Simpson DJ; Magnay J; Bicknell JE; Barkan AL; McNicol AM; Clayton RN; Farrell WE Cancer Res; 1999 Apr; 59(7):1562-6. PubMed ID: 10197629 [TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. Cleton-Jansen AM; Collins N; Lakhani SR; Weissenbach J; Devilee P; Cornelisse CJ; Stratton MR Br J Cancer; 1995 Nov; 72(5):1241-4. PubMed ID: 7577475 [TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma. Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185 [TBL] [Abstract][Full Text] [Related]
18. Widespread bimodal intrachromosomal genomic instability in sporadic breast cancers associated with 13q allelic imbalance. Przybytkowski E; Girouard S; Allard B; Lamarre L; Basik M Cancer Res; 2003 Aug; 63(15):4588-93. PubMed ID: 12907636 [TBL] [Abstract][Full Text] [Related]
19. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. Gretarsdottir S; Thorlacius S; Valgardsdottir R; Gudlaugsdottir S; Sigurdsson S; Steinarsdottir M; Jonasson JG; Anamthawat-Jonsson K; Eyfjörd JE Cancer Res; 1998 Mar; 58(5):859-62. PubMed ID: 9500438 [TBL] [Abstract][Full Text] [Related]
20. Mutations of the BRCA2 gene in ovarian carcinomas. Takahashi H; Chiu HC; Bandera CA; Behbakht K; Liu PC; Couch FJ; Weber BL; LiVolsi VA; Furusato M; Rebane BA; Cardonick A; Benjamin I; Morgan MA; King SA; Mikuta JJ; Rubin SC; Boyd J Cancer Res; 1996 Jun; 56(12):2738-41. PubMed ID: 8665505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]